Medibio Limited reported earnings results for the half year ended December 31, 2021. For the half year, the company reported sales was AUD 0.013376 million compared to AUD 0.080834 million a year ago. Net loss was AUD 0.644694 million compared to AUD 0.741807 million a year ago.

Basic loss per share from continuing operations was AUD 0.0004 compared to AUD 0.0006 a year ago. Diluted loss per share from continuing operations was AUD 0.0004 compared to AUD 0.0006 a year ago.